AVR 1.29% $18.31 anteris technologies ltd

Only those who received the vaccine experienced a t-cell...

  1. 272 Posts.
    lightbulb Created with Sketch. 36
    Only those who received the vaccine experienced a t-cell response. The placebo group didn't.

    Ergo, technology works.

    As far as I can see, neither Rational Vaccines or Genocea have achieved the same results.

    Once AHZ communicates a respectable path toward break even, and demonstrates revenue growth, investors will pile in.
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
(20min delay)
Last
$18.31
Change
-0.240(1.29%)
Mkt cap ! $351.9M
Open High Low Value Volume
$18.80 $19.15 $18.20 $159.7K 8.611K

Buyers (Bids)

No. Vol. Price($)
1 73 $18.31
 

Sellers (Offers)

Price($) Vol. No.
$18.33 90 1
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
AVR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.